Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01991808 · ClinicalTrials.gov registry record · NA
Suitability of DCE-MRI for Detection of Vascular Changes After VBT
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT01991808 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 16 participants.
The verdict
NCT01991808, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This is a pilot study of DCE MR imaging to detect vascular changes in the vagina during and after radiotherapy n patients receiving adjuvant brachytherapyfor cervical or endometrial cancer.
Interventions
- RADIATION Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-12-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01991808
The ClinicalTrials.gov registry entry for NCT01991808 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiotherapy is the first listed.
NCT01991808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01991808 about?
NCT01991808 is a clinical study titled "Suitability of DCE-MRI for Detection of Vascular Changes After VBT". This is a pilot study of DCE MR imaging to detect vascular changes in the vagina during and after radiotherapy n patients receiving adjuvant brachytherapyfor cervical or endometrial cancer.
What is the current status of trial NCT01991808?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2013-10. Estimated completion is 2016-12-08.
What interventions are being tested in trial NCT01991808?
The interventions under investigation include: Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT01991808?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.